| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |